Introduction
The NF-kB family of transcription factors regulates diverse biological processes, including immune responses, inflammation, cell growth, and apoptosis (Barkett and Gilmore, 1999; Silverman and Maniatis, 2001; Karin and Lin, 2002) . Mammalian cells contain five NF-kB members, RelA, RelB, c-Rel, p50, and p52, which bind to a target DNA sequence (kB) as different homo-and heterodimers (Siebenlist et al., 1994) . Different NF-kB members appear to mediate distinct biological functions, although redundancy also exists among some of them. The composition of NF-kB complexes is at least partially controlled by the biogenesis of p50 and p52. These two NF-kB DNAbinding subunits are produced as large precursor proteins, the nfkb1 gene product p105 and the nfkb2 gene product p100, which undergo proteasomemediated processing to become the mature p50 and p52 proteins (Karin and Ben-Neriah, 2000) . The NF-kB proteins are normally sequestered in the cytoplasm as inactive complexes with a family of ankyrin repeatcontaining inhibitors termed inhibitor kB (IkB) (Baldwin, 1996) . Activation of NF-kB occurs when cells are stimulated with cytokines, mitogens, and various other environmental stimuli (Karin and Ben-Neriah, 2000) . The canonical NF-kB activation is mediated by stimulation of a large IkB kinase (IKK) complex, composed of two catalytic subunits, IKKa and IKKb, and a regulatory subunit termed IKKg or NEMO (NFkB essential modulator) (Karin and Ben-Neriah, 2000) . Upon activation, IKK phosphorylates the IkBs, triggering their ubiquitination by the SCF bTrCP ubiquitin ligase and subsequent degradation, thus allowing the NF-kB dimers to move to the nucleus and exert their transactivation function.
The processing of p105 and p100 forms another level of NF-kB regulation. In addition to serving as the precursors of p50 and p52, these large proteins function as IkB-like molecules (Rice, 1992; Mercurio, 1993; Sun, 1994) . Like the typical IkBs, both p105 and p100 contain ankyrin repeats in their Cterminal portion and can sequester specific NF-kB members in the cytoplasm. Recent evidence suggests that p105 also functions as a regulator of the MAP kinase signaling pathway (Waterfield et al., 2003) . The processing of p100 and p105 involves proteasomemediated degradation of their C-terminal half covering the ankyrin repeat domain (ARD) (Fan and Maniatis, 1991; Siebenlist et al., 1994) . Thus, the precursor processing not only leads to generation of p52 and p50, but also results in the disruption of the IkB-like function. The processing of p105 is largely constitutive, although certain stimuli may trigger complete degradation or enhanced processing of p105 (Harhaj et al., 1996; Belich et al., 1999; Heissmeyer et al., 1999; Orian et al., 2000) . In contrast, the processing of p100 is tightly regulated (Xiao et al., 2001b) . Under normal conditions, the processing of p100 is regulated by a noncanonical NF-kB signaling pathway involving NF-kB-inducing kinase (NIK) (Xiao et al., 2001b) and IKKa (Senftleben et al., 2001) , which can be stimulated by signals regulating B-cell maturation and lymphoid organogenesis (Claudio et al., 2002; Coope et al., 2002; Dejardin et al., 2002; Kayagaki et al., 2002) . Aberrant processing of p100 has been found in leukemia T cells transformed by the human T-cell leukemia virus, in which the processing is induced by the viral oncoprotein Tax in a NIK-independent and IKKa-dependent mechanism (Xiao et al., 2001a) .
Deregulated processing of p100 can also result from structural alterations of p100 (Xiao et al., 2001b) . The C-terminal region of p100 contains a processing-inhibitory domain (PID) that is important for preventing the constitutive processing of p100 (Xiao et al., 2001b) . Interestingly, the core region of the PID corresponds to a death domain (DD), previously identified based on sequence homology to the DDs present in various apoptosis-regulatory proteins (Feinstein et al., 1995) . Deletion of the DD is sufficient to trigger constitutive processing of p100 (Xiao et al., 2001b) . Of note, the gene encoding p100 (nfkb2) is frequently involved in chromosomal translocations associated with development of lymphomas, and in all cases studied, such oncogenic alterations involve generation of C-terminally truncated p100 molecules lacking the PID and part of the ARD. These findings suggest that deregulated p100 processing (or generation of p52) may contribute to the development of lymphoid malignancies. In support of this idea, genetically manipulated mice carrying a C-terminal truncation mutant of the nfkb2 gene (produces p52 but not p100) develop gastric and lymphoid hyperplasia (Ishikawa et al., 1997) .
Despite the functional connections described above, the mechanism regulating the constitutive processing of p100 remains unknown. Specifically, it is not clear how the C-terminal region of p100 suppresses p100 processing. In the present study, we have demonstrated that the constitutive processing of p100 is regulated by its nuclear translocation. Both the C-terminal DD and the ARD of p100 contribute to the cytoplasmic retention and processing inhibition of p100. We provide direct evidence suggesting the essential role for p100 nuclear shuttling in regulating its constitutive processing.
Results
The level of constitutive processing of p100 mutants is correlated with their nuclear translocation activity As described above, the C-terminal PID of p100 is important for suppressing the constitutive processing of p100. However, how the PID participates in processing inhibition remains unknown. A recent study suggests that the C-terminal portion of p100 has nuclear-exporting function (Solan et al., 2002) . We thus examined the role of the PID in regulating the subcellular localization of p100. For these studies, C-terminal truncations and an internal deletion were performed to remove the DD and its flanking sequences within p100 ( Figure 1a At about 40 h post-transfection, the expression of p100 precursors and the processing product, p52, were analysed by immunoblotting using the N-terminal-specific anti-p100 antibody. The protein bands in (c) were quantitated by densitometry and presented as ratio (in percentage) between the processing product (p52) and the precursors (lower part of (c). (d) Immunofluorescence analysis to determine the subcellular localization of p100 and its mutants. COS cells were transfected in 24-well plates with the WT or mutant forms of HA-tagged p100 (100 ng). The subcellular localization of the transfected p100 proteins was detected by indirect immunofluorescence assays using anti-HA (WT, 1-859, 1-753, 1-665) or a C-terminal specific anti-p100 (DDD) primary antibody and FITC-conjugated anti-mouse Ig secondary antibody (upper panels). To localize the nuclei of the cells, the cells were counterstained with a DNA-staining dye (Hoechst 33258) and visualized with a UV filter (lower panels)
NF-jB2/p100 processing G Liao and S-C Sun resultant p100 constructs were fused, at the C-terminus, with a copy of HA epitope tag for facilitating immunofluorescence detection of their nonprocessed forms. Immunoblot (IB) assays showed that the processing phenotype of the C-terminal-tagged p100 and mutants was largely the same as that of their untagged counterparts (Figure 1b ; Xiao et al., 2001b) . The wildtype p100 and p100 (1-859) were hardly processed (as defined by generation of the processing product p52) (Figure 1b , lanes 1 and 2), while those p100 mutants lacking the DD (1-753 and DDD) exhibited constitutive processing activity (lanes 3 and 4). A mutant (1-665) lacking part of the ARD as well as downstream sequences exhibited higher levels of processing activity (Figure 1c) .
Indirect immunofluorescence assays revealed that the wildtype p100 is primarily located in the cytoplasm (Figure 1d) . Deletion of the sequence located downstream of the DD did not alter the pattern of p100 subcellular localization (Figure 1d , 1-859). Interestingly, however, further deletion to remove the DD generated a p100 mutant (1-753) that was located in both the cytoplasm and nucleus. Similarly, a p100 mutant harboring an internal deletion of the DD (DDD) exhibited whole-cell expression pattern. Further, the p100 mutant 1-665, with higher processing activity (see Figure 1c) , was predominantly nuclear. The difference of the p100 mutants in nuclear localization appeared to be due to their efficiency in nuclear import, rather than nuclear export, since the pattern of their subcellular localization was not altered when the cells were incubated with the nuclear export inhibitor leptomycine B (LMB) (Fukuda et al., 1997) (data not shown). Together, these results indicate that the constitutive processing of p100 mutants is correlated with their nuclear shuttling activity.
The ARD of p100 affects the efficiency of nuclear translocation and processing of p100
The ARD of IkB proteins has been implicated in masking the nuclear localization signal (NLS) of NF-kB in the latent NF-kB complexes (Baldwin, 1996) . The result obtained with the p100 mutant 1-665 (Figure 1) suggested the possibility for the involvement of the ARD in preventing p100 nuclear translocation. We thus reasoned that if nuclear translocation is indeed required for p100 processing, disruption of the ARD might promote both the nuclear translocation and processing of the resulting p100 mutants. To examine this possibility, we generated p100 mutants lacking different ankyrin repeats: p100DAnk1-3 (deletion of ankyrin repeat 1-3), p100DAnk5-7 (deletion of ankyrin repeat 5-7), and p100DAnk1-3/5-7 (deletion of ankyrin repeat 1-3 and 5-7) (Figure 2a) . Immunofluorescence assays showed that, at their steady state, p100DAnk1-3 and p100DAnk5-7 exhibited a whole-cell localization pattern, while the p100DAnk1-3/5-7 was predominantly nuclear (Figure 2b) . Interestingly, all these ankyrinrepeat mutants accumulated in the nucleus upon LMB treatment (Figure 2b , LMB TREATED). In contrast, the WT p100 was still retained in the cytoplasm in the treated cells. Together, these data strongly suggest that disruption of the ARD allows p100 to actively shuttle between the cytoplasm and nucleus. Furthermore, these data also supported the previous finding that the Cterminus of p100 has nuclear export function (Solan et al., 2002) .
We then determined whether the nuclear shuttling activity of the p100 variants promotes their processing. The WT p100 and its DAnk mutants were subjected to processing analysis by IB. Interestingly, while the WT p100 was not processed, all its DAnk variants underwent active processing, generating high levels of p52 (Figure 2c ). These results further support the idea that nuclear shuttling is involved in regulation of p100 processing.
The nuclear localization signal of p100 is essential for p100 processing
To directly determine whether nuclear translocation is essential for p100 processing, we mutated the NLS in an actively processing form of p100, p100DAnk1-3/5-7. As expected, the generated mutant, p100DA1-3/5-7DNLS, was located only in the cytoplasm, even when the cells were incubated with LMB ( Figure 3a , DAnk1-3/5-7DNLS). More importantly, the block of nuclear translocation was associated with the loss of processing of this p100 variant (Figure 3b, lane 2) . To further confirm the role of nuclear translocation in regulating p100 processing, we fused a heterologous NLS from the large T antigen of SV40 virus to either the N-or Cterminus of the p100 DNLS mutant. Probably due to the location, the heterologous NLS was not as strong as the original one, since the resulting p100 mutants were located in the cytoplasm at their steady state (Figure 3a , DAnk1-3/5-7DNLS-5 0 NLS and DAnk1-3/5-7DNLS-3 0 NLS). Nevertheless, these mutants were actively shuttling to the nucleus, because they were accumulated to the nuclear compartment upon LMB treatment (LMB treated). This situation was reminiscent of the p100DAnk1-3 and p100DAnk5-7 proteins (see Figure 2b ). More importantly, the heterologous NLS also rescued the constitutive processing of the p100 mutant (Figure 3b,c) .
To confirm that the NLS-dependent processing is not limited to one p100 mutant, we mutated the NLS in two other p100 mutants, 1-753 and DDD. As expected, the processing of these two mutants was also crippled when their NLS was mutated (Figure 3d) . These results clearly demonstrate that the nuclear shuttling activity of p100 mutants is essential for their constitutive processing.
We then investigated whether the NLS is also required for the inducible processing of p100. For these studies, the NLS was mutated in the full-length p100, and the resulting p100DNLS or its wildtype counterpart was expressed in 293 cells either alone or together with the processing inducing kinase NIK. Interestingly, mutation of the NLS significantly diminished, although did not completely block, the NIK-induced p100 processing (Figure 3e , compare both the precursor and processing product). Thus, the NLS is not only essential for the constitutive processing of p100 mutants, but also partially involved in the inducible processing of wildtype p100.
Discussion
NF-kB2/p100 is a member of IkB family that appears to play a critical role in maintaining the physiological role of NF-kB. Chromosomal translocations involving the nfkb2 gene have been frequently detected in certain types of lymphomas and leukemia (Neri et al., 1996; Rayet and Gelinas, 1999) . These genetic alterations always disrupt the exons coding for the C-terminal portion of p100. Although it is unclear how the Cterminal truncations of p100 contribute to tumorigenesis, recent studies suggest that overproduction of p52 and loss of IkB-like function of p100 may play a key role. Mice carrying homozygous deletion of the C-terminal portion of p100, which constitutively produce p52, develop gastric and lymphoid hyperplasia (Ishikawa et al., 1998) . Consistently, the C-terminal truncation mutants of p100, corresponding to the products of the genetically altered nfkb2 genes from lymphoma cells, undergo constitutive processing (Xiao et al., 2001b) . We have previously shown that the constitutive processing of the p100 mutants was due to their loss of a PID (Xiao et al., 2001b) , although how the PID regulates the processing activity of p100 has remained unknown.
The data presented in the current study demonstrate a novel mechanism of processing regulation. We have shown that the constitutive processing of p100 is regulated by its active nuclear shuttling function. All the constitutively processed p100 mutants exhibit nuclear shuttling activity. More importantly, the processing of such p100 variants could be largely blocked by mutation of their NLS (Figure 3) . Furthermore, fusion of a heterologous NLS to either the N-or C-terminus of a p100DNLS mutant rescues its processing function (Figure 3b,c) . It remains to be further investigated how the nuclear shuttling of p100 mutants triggers their Immunofluorescence analysis to determine the subcellular localization of p100 and its ARD deletion mutants. As indicated, some of the cells were treated with LMB for 5 h before staining using the C-terminal-specific anti-p100 (antip100C) primary antibody followed by FITC-conjugated anti-rabbit Ig secondary antibody. The nuclei were counterstained with Hoechst. (c) Processing analysis of p100 and its ARD deletion mutants. COS cells were transfected with the WT p100 or the indicated ARD deletion mutants and subjected to IB assays (using anti-p100N antibody) to detect the processing of the transfected p100 proteins NF-jB2/p100 processing G Liao and S-C Sun processing. One possibility is that certain factors regulating the p100 processing are located in the nucleus. In this regard, recent studies have revealed the predominant nuclear localization of ubiquitinationcatalyzing enzymes ( e Figure 3 The NLS of p100 is essential for its constitutive processing and partially required for its inducible processing. (a) Immunofluorescence analysis to determine the nuclear shuttling activity of p100DAnk1-3/5-7 and its variants. p100DAnk1-3/5-7DNLS harbors mutations at the conserved NLS (KRRK) located at amino acids 338-341; p100DAnk1-3/5-7DNLS-5 0 NLS and p100DAnk1-3/5-7DNLS-3 0 NLS contain a heterologous NLS (from the SV40 large T antigen) at the N-and C-terminus, respectively. The p100 wildtype (WT) was used as negative control. The immunofluorescence assays were performed as described in Figure 1d using the C-terminal-specific anti-p100 antibody. (b, c) IB analysis to determine the processing of p100DAnk1-3/5-7 and its variants. COS cells were transfected with the unmodified (WT) p100DAnk1-3/5-7 and the indicated variants and subjected to IB assays using antip100N antibody. The intensity of the bands was quantitated by densitometry and presented as ratio (in percentage) between the processing product p52 and its precursors (c). (d) IB analysis to determine the role of NLS in the processing of p100(1-753) and p100DDD. 293 cells were transfected with the unmodified (WT) or NLS mutated (DNLS, two clones) forms of p100(1-753) and p100DDD. The processing was analysed by IB assays. (e) IB analysis to determine the role of NLS in NIK-induced p100 processing. 293 cells were transfected with unmodified (WT) or NLS mutated (DNLS) forms of full-length (FL) p100 either in the absence (À) or presence ( þ ) of NIK. The processing of p100 was analysed by IB NF-jB2/p100 processing G Liao and S-C Sun
Although ubiquitination of the constitutively processed forms of p100 has been difficult to detect (data not shown), the possibility that such processing is ubiquitindependent cannot be excluded, since the sensitivity of the assay protocol (Xiao et al., 2001b) is low. It is also possible that a nuclear factor is required for the proteasome targeting of the p100 mutants. Notwithstanding, our data clearly demonstrate that nuclear shuttling is an essential step that controls the constitutive processing of p100. The processing of p100 under physiological conditions is mediated by a noncanonical NF-kB signaling pathway involving the NIK kinase. The mechanisms mediating constitutive and inducible processing of p100 appear to differ at least in certain aspects. For example, the inducible, but not constitutive, processing is dependent on the SCF b-TrCP ubiquitin ligase (Fong and Sun, 2002 ). In the current study, we have shown that the NIK-induced p100 processing is only partially affected by mutation of the p100 NLS (Figure 3e ), while the constitutive processing of the p100 mutants is largely abolished by such modification (Figure 3b-d) . It is thus likely that the inducible processing of p100 may involve both NLS-dependent and independent mechanisms, while the constitutive processing relies on the NLSdependent mechanism.
Materials and methods

Expression vectors and antibodies
The expression vector encoding p100 (pCMV4-p100) was kindly provided by Dr WC Greene (Sun et al., 1994) . The truncation and internal deletion mutants of p100 were generated by PCR and site-directed mutagenesis, respectively. Where indicated, the p100 constructs were cloned into an expression vector (pCMV4) containing a copy of the hemagglutinin (HA) epitope tag, yielding C-terminally tagged p100 proteins. To create the DNLS mutant of p100, sitedirected mutagenesis was performed to mutate the core NLS sequence of p100 (KRRK, amino acids 338-341) to alanines (AAAA). Functional rescue of the DNLS mutant was carried out (using PCR) by incorporating a DNA fragment encoding the SV40 large T antigen NLS (PKKKRKV) to either the 5 0 (5 0 NLS) or 3 0 (3 0 NLS) end of the DNLS p100 cDNA. The p50-GFP-NES was constructed by fusing the green fluorescence protein (GFP) and the nuclear export signal (NES) sequence of RelA to the C-terminus of NF-kB p50 (Harhaj and Sun, 1999) . This fusion protein undergoes rapid shuttling between the cytoplasm and nucleus (Harhaj and Sun, 1999) . The anti-HA (12A5) and HRP-conjugated anti-HA antibody (3F10) antibodies were purchased from Roche Molecular Biochemicals. The antibody recognizing the N-and C-terminus of p100 (antip100N and anti-p100C) was kindly provided by Drs WC Greene (Sun et al., 1994) and NR Rice (Rice et al., 1992) , respectively. The fluorescein isothiocyanate (FITC)-conjugated anti-mouse and anti-rabbit secondary antibodies were purchased from Amersham Pharmacia Biotech.
Indirect immunofluorescence assays
Monkey kidney COS cells were cultured in Iscove's medium supplemented with 10% fetal bovine serum, 2 mm l-glutamine, and antibiotics. The cells were transfected in 24-well plates using Fugene reagent (Roche Molecular Biochemicals). After about 24 h, the recipient cells were fixed, permeabilized, and sequentially incubated with the indicated primary antibodies, followed by FITC-conjugated secondary antibodies (Harhaj and Sun, 1999) . The subcellular localization of transfected proteins was detected using an inverted fluorescence microscope. The cells were also counterstained with Hoechst 33258 (Sigma), as previously described (Harhaj and Sun, 1999) , and visualized with UV filter. To block protein nuclear export, the transfected cells were incubated with 10 ng/ml of leptomycin B (LMB, Fukuda et al., 1997) for 5 h prior to the immunofluorescence staining.
Immunoblotting (IB)
COS or human kidney carcinoma 293 cells were transfected using DEAE-dextran, as previously described (Ganchi et al., 1992) . At about 40 h post-transfection, whole-cell lysates were prepared using RIPA buffer supplemented with protease inhibitors (Xiao et al., 2001a) and subjected to SDS-PAGE and IB. The intensity of the protein bands was quantitated by densitometry.
